July 9 (Reuters) - Moderna said on Thursday it has secured a European Commission contract to supply its respiratory syncytial ...

The panel unanimously said that the benefits of Moderna's mRNA jab outweigh its risks in preventing influenza in certain age groups.

Moderna gains fresh market attention after a unanimous flu vaccine panel vote strengthens confidence in its mRNA vaccine ...

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

Over 156,000 adults in Europe are hospitalised each year due to RSV, a virus that can cause severe lung issues.

By Christy Santhosh and Mariam Sunny June 18 (Reuters) - Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying its ...

Find the latest covid vaccine news from Fast company. See related business and technology articles, photos, slideshows and ...

Moderna (NASDAQ:MRNA) stock is jumping again. Shares are up 9% today, trading near $57 in the Tuesday afternoon session. That extends a remarkable 2026 run for the mRNA pioneer. The move pushes ...

Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots ​against Ebola Bundibugyo, the deadly virus that has swept through ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. BOSTON — Over the last year, venture ...

Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

Biotech is the story at midday Friday, and it’s not a pretty one for shareholders who chased the sector’s monster 2026 run.